Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Fibromyalgia (FM) is a medical condition characterised by chronic widespread pain and a heightened pain response to pressure.
The APAC is a major untapped market with many leading vendors in the global fibromyalgia drugs market.
The report details the trend, potential and market size of Fibromyalgia Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Fibromyalgia Drugsmarket, defines the market attractiveness level of Fibromyalgia Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Fibromyalgia Drugs industry, describes the types of Fibromyalgia Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Fibromyalgia Drugs market and the development prospects and opportunities of Fibromyalgia Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Fibromyalgia Drugs market in Chapter 13.
By Player:
Switch Biotech
Theravance
Merck Sharp and Dohme
Meda
Tonix Pharmaceuticals Holding Corp
Pfizer
Actavis
Daiichi Sankyo
Meiji Seika
Zynerba Pharmaceuticals
Innovative Med Concepts
Eli Lilly
By Type:
Serotonin Norepinephrine Reuptake Inhibitors
GABA Analogs
Other
By End-User:
Hospitals
Clinics
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Fibromyalgia Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Fibromyalgia Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Fibromyalgia Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Fibromyalgia Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Fibromyalgia Drugs Market Analysis and Outlook to 2022
-
7.1 Global Fibromyalgia Drugs Consumption (2017-2022)
-
7.2 United States Fibromyalgia Drugs Consumption (2017-2022)
-
7.3 Europe Fibromyalgia Drugs Consumption (2017-2022)
-
7.4 China Fibromyalgia Drugs Consumption (2017-2022)
-
7.5 Japan Fibromyalgia Drugs Consumption (2017-2022)
-
7.6 India Fibromyalgia Drugs Consumption (2017-2022)
-
7.7 South Korea Fibromyalgia Drugs Consumption (2017-2022)
8 Region and Country-wise Fibromyalgia Drugs Market Analysis and Outlook to 2028
-
8.1 Global Fibromyalgia Drugs Consumption Forecast (2022-2028)
-
8.2 United States Fibromyalgia Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Fibromyalgia Drugs Consumption Forecast (2022-2028)
-
8.4 China Fibromyalgia Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Fibromyalgia Drugs Consumption Forecast (2022-2028)
-
8.6 India Fibromyalgia Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Fibromyalgia Drugs Consumption Forecast (2022-2028)
9 Global Fibromyalgia Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Fibromyalgia Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Serotonin Norepinephrine Reuptake Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global GABA Analogs Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Fibromyalgia Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Fibromyalgia Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Fibromyalgia Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Serotonin Norepinephrine Reuptake Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global GABA Analogs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Fibromyalgia Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Fibromyalgia Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Fibromyalgia Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Fibromyalgia Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Fibromyalgia Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Fibromyalgia Drugs Market Competitive Analysis
-
14.1 Switch Biotech
-
14.1.1 Switch Biotech Company Details
-
14.1.2 Switch Biotech Fibromyalgia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Switch Biotech Fibromyalgia Drugs Product and Service
-
14.2 Theravance
-
14.2.1 Theravance Company Details
-
14.2.2 Theravance Fibromyalgia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Theravance Fibromyalgia Drugs Product and Service
-
14.3 Merck Sharp and Dohme
-
14.3.1 Merck Sharp and Dohme Company Details
-
14.3.2 Merck Sharp and Dohme Fibromyalgia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Merck Sharp and Dohme Fibromyalgia Drugs Product and Service
-
14.4 Meda
-
14.4.1 Meda Company Details
-
14.4.2 Meda Fibromyalgia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Meda Fibromyalgia Drugs Product and Service
-
14.5 Tonix Pharmaceuticals Holding Corp
-
14.5.1 Tonix Pharmaceuticals Holding Corp Company Details
-
14.5.2 Tonix Pharmaceuticals Holding Corp Fibromyalgia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Tonix Pharmaceuticals Holding Corp Fibromyalgia Drugs Product and Service
-
14.6 Pfizer
-
14.6.1 Pfizer Company Details
-
14.6.2 Pfizer Fibromyalgia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Pfizer Fibromyalgia Drugs Product and Service
-
14.7 Actavis
-
14.7.1 Actavis Company Details
-
14.7.2 Actavis Fibromyalgia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Actavis Fibromyalgia Drugs Product and Service
-
14.8 Daiichi Sankyo
-
14.8.1 Daiichi Sankyo Company Details
-
14.8.2 Daiichi Sankyo Fibromyalgia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Daiichi Sankyo Fibromyalgia Drugs Product and Service
-
14.9 Meiji Seika
-
14.9.1 Meiji Seika Company Details
-
14.9.2 Meiji Seika Fibromyalgia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Meiji Seika Fibromyalgia Drugs Product and Service
-
14.10 Zynerba Pharmaceuticals
-
14.10.1 Zynerba Pharmaceuticals Company Details
-
14.10.2 Zynerba Pharmaceuticals Fibromyalgia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Zynerba Pharmaceuticals Fibromyalgia Drugs Product and Service
-
14.11 Innovative Med Concepts
-
14.11.1 Innovative Med Concepts Company Details
-
14.11.2 Innovative Med Concepts Fibromyalgia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Innovative Med Concepts Fibromyalgia Drugs Product and Service
-
14.12 Eli Lilly
-
14.12.1 Eli Lilly Company Details
-
14.12.2 Eli Lilly Fibromyalgia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Eli Lilly Fibromyalgia Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Fibromyalgia Drugs
-
Figure Fibromyalgia Drugs Picture
-
Table Global Fibromyalgia Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Fibromyalgia Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Fibromyalgia Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Fibromyalgia Drugs Consumption by Country (2017-2022)
-
Figure United States Fibromyalgia Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Fibromyalgia Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Fibromyalgia Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Fibromyalgia Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Fibromyalgia Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Fibromyalgia Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Fibromyalgia Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Fibromyalgia Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Fibromyalgia Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Fibromyalgia Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Fibromyalgia Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Fibromyalgia Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Fibromyalgia Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Serotonin Norepinephrine Reuptake Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global GABA Analogs Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Serotonin Norepinephrine Reuptake Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global GABA Analogs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Fibromyalgia Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Fibromyalgia Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Switch Biotech (Foundation Year, Company Profile and etc.)
-
Table Switch Biotech Fibromyalgia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Switch Biotech Fibromyalgia Drugs Product and Service
-
Table Theravance (Foundation Year, Company Profile and etc.)
-
Table Theravance Fibromyalgia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Theravance Fibromyalgia Drugs Product and Service
-
Table Merck Sharp and Dohme (Foundation Year, Company Profile and etc.)
-
Table Merck Sharp and Dohme Fibromyalgia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Sharp and Dohme Fibromyalgia Drugs Product and Service
-
Table Meda (Foundation Year, Company Profile and etc.)
-
Table Meda Fibromyalgia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Meda Fibromyalgia Drugs Product and Service
-
Table Tonix Pharmaceuticals Holding Corp (Foundation Year, Company Profile and etc.)
-
Table Tonix Pharmaceuticals Holding Corp Fibromyalgia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tonix Pharmaceuticals Holding Corp Fibromyalgia Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Fibromyalgia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Fibromyalgia Drugs Product and Service
-
Table Actavis (Foundation Year, Company Profile and etc.)
-
Table Actavis Fibromyalgia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Actavis Fibromyalgia Drugs Product and Service
-
Table Daiichi Sankyo (Foundation Year, Company Profile and etc.)
-
Table Daiichi Sankyo Fibromyalgia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Fibromyalgia Drugs Product and Service
-
Table Meiji Seika (Foundation Year, Company Profile and etc.)
-
Table Meiji Seika Fibromyalgia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Meiji Seika Fibromyalgia Drugs Product and Service
-
Table Zynerba Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Zynerba Pharmaceuticals Fibromyalgia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zynerba Pharmaceuticals Fibromyalgia Drugs Product and Service
-
Table Innovative Med Concepts (Foundation Year, Company Profile and etc.)
-
Table Innovative Med Concepts Fibromyalgia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Innovative Med Concepts Fibromyalgia Drugs Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Fibromyalgia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Fibromyalgia Drugs Product and Service
-
